Individuals exposed to glyphosate-based weed killers may be eligible to seek compensation for cancer diagnoses and long-term health complications linked to repeated Roundup exposure.
Roundup litigation involves thousands of claims alleging that exposure to glyphosate — the active ingredient in Roundup weed killer — increased the risk of developing non-Hodgkin’s lymphoma and related cancers.
Plaintiffs argue that manufacturers marketed the herbicide as safe for decades despite scientific studies suggesting potential carcinogenic risks. Lawsuits claim companies failed to adequately warn consumers, landscapers, farmers, and groundskeepers about long-term exposure dangers.
Cases have resulted in major jury verdicts and settlements, making Roundup litigation one of the largest product liability mass torts in U.S. history.
Roundup is one of the most widely used herbicides worldwide and has been commonly applied in agriculture, residential landscaping, parks, and commercial property maintenance since the 1970s.
The product contains glyphosate, a chemical designed to kill weeds by blocking plant growth enzymes. Critics allege prolonged human exposure through spraying, inhalation, or skin contact may pose serious health risks.
Frequent users — including farmers, gardeners, and maintenance workers — are believed to face higher exposure levels due to repeated application.
Scientific debate surrounding glyphosate intensified after international health agencies classified the chemical as a probable human carcinogen. Studies reviewed in litigation examine occupational exposure patterns, toxicology data, and epidemiological research linking glyphosate exposure to lymphoma development.
Expert witnesses evaluate whether repeated exposure can trigger cellular damage, immune system disruption, or genetic mutations associated with cancer.
Courts analyze competing scientific opinions to determine liability and the adequacy of product warnings provided to consumers.
Most commonly alleged cancer associated with glyphosate exposure.
Cancer affecting immune system cells examined in litigation studies.
Blood cancer investigated in occupational exposure research.
Possible immune suppression linked to chemical exposure.
Reported symptoms among long-term applicators.
Under investigation in toxicology studies.
You may qualify if you regularly used Roundup or were occupationally exposed to glyphosate products and later developed a qualifying cancer diagnosis.
Repeated exposure during crop treatment.
Frequent commercial herbicide application.
Long-term household weed control usage.
Roundup lawsuits have produced multiple high-profile jury verdicts awarding substantial compensation to plaintiffs diagnosed with cancer after long-term exposure. Many claims are coordinated within multidistrict litigation proceedings.
Settlement negotiations continue while additional cases proceed through trial phases across various jurisdictions.
Compensation may depend on diagnosis severity, exposure duration, medical expenses, and personal damages.
Documentation such as employment history, purchase records, or witness statements may help demonstrate exposure but eligibility is evaluated individually.
No. Claims are handled on a contingency basis, meaning fees are only deducted from a successful settlement or verdict.
Yes. Each plaintiff maintains an individual claim while benefiting from shared scientific evidence in mass tort proceedings.
Submit your information for a free case evaluation. You pay nothing unless compensation is recovered.
Start Free Case Review